financetom
Business
financetom
/
Business
/
Goldman Sachs highlights diversity in new partner class
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Goldman Sachs highlights diversity in new partner class
Nov 13, 2020 12:22 AM

Goldman Sachs Group Inc has invited 60 executives to become partners as of Jan. 1, nearly half of them from diverse backgrounds, the bank said on Thursday. Goldman’s partners collectively own a small stake in the firm and are the bank’s most elite employees, typically taking home million-dollar salary packages and having access to lucrative investment opportunities.

The bank said 47 percent of this year’s class are either women, Black, Asian or Latino. Forty-three are based in America, with 13 in Europe, the Middle East and Africa, three in the Asia-Pacific region and one in Bengaluru. Sixteen of the new partners are women, it said. In technology investment banking, a unit the bank has heavily invested in, seven new partners were named.

Jane Dunlevie, 35, is among the youngest partners promoted on Thursday, after spending 11 years with the bank. As co-head of global internet investment banking, she has been advising high-profile clients such as Shopify and Pinterest.

”There has been so much activity in the internet sector and tech more broadly, which has contributed to the success of all of my TMT colleagues that are being promoted today,” Dunlevie said in an interview.

Chief Executive David Solomon has said he wants to move faster to increase diversity among the bank’s senior ranks.

Goldman has set some of the most aggressive and specific goals among the big banks, requiring that more Black, Latino and female professionals be interviewed and hired for jobs at the bank. The bank interviews at least two diverse candidates for any senior job opening. Despite that, Solomon has said the bank is not increasing diversity fast enough.

Goldman’s partnership ranks have nearly doubled since the bank went public in 1999, but have shrunk over the last decade as part of a strategy to make the Wall Street bank less top-heavy. Under Solomon, who took over as the bank’s chief executive officer in 2018, that trend has continued.

Goldman named 69 new partners two years ago during Solomon’s first year in the role.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gucci's steep sales decline throws spotlight on China
Gucci's steep sales decline throws spotlight on China
Mar 20, 2024
By Mimosa Spencer PARIS (Reuters) - Shares of Kering are expected to open down on Wednesday, after the company warned first quarter sales at its star label Gucci would drop by around 20% due to weakness in Asia. The warning underscores the challenge Kering faces as it seeks to reignite sales momentum at Gucci, which accounts for half of group...
Oil retreats from multi-month highs, strong dollar dents demand
Oil retreats from multi-month highs, strong dollar dents demand
Mar 20, 2024
SINGAPORE (Reuters) -Oil prices edged lower on Wednesday, as a stronger dollar curbed investor appetite while traders took some money off the table after benchmarks rallied to multi-month highs in the previous session. Brent crude futures for May fell 28 cents, or 0.3%, to $87.10 a barrel by 0711 GMT. U.S. West Texas Intermediate futures for April delivery, which expire...
Lonza to buy biologics site from Roche in U.S. for $1.2 billion
Lonza to buy biologics site from Roche in U.S. for $1.2 billion
Mar 19, 2024
ZURICH (Reuters) -Swiss contract drug manufacturer Lonza said on Wednesday it has signed an agreement to acquire the Genentech manufacturing facility in Vacaville, California, from drugmaker Roche for $1.2 billion in cash. Lonza plans to invest around 500 million Swiss francs ($562.30 million) to upgrade the facility and enhance capabilities at the site to accommodate the next generation of mammalian...
Lonza to buy biologics site from Roche in US for $1.2 bln
Lonza to buy biologics site from Roche in US for $1.2 bln
Mar 19, 2024
ZURICH, March 20 (Reuters) - Swiss contract drug manufacturer Lonza said on Wednesday it has signed an agreement to acquire the Genentech manufacturing facility in Vacaville, California, from drugmaker Roche for $1.2 billion in cash. Lonza plans to invest around 500 million Swiss francs ($562.3 million) to upgrade the facility and enhance capabilities at the site to accommodate the next...
Copyright 2023-2026 - www.financetom.com All Rights Reserved